Generic drug
Prasugrel price, strengths & recalls
Pharmacies pay $7.67 for 30 tablets of Prasugrel 10 mg tablet this week, and from $7.67 to $7.72 across its 2 priced strengths and forms. 8 manufacturers make it. 4 recalls are ongoing. Its official label last changed on November 9, 2026.
4 open recallsGeneric- Fair cash price
- $19.32
- Strengths
- 2
- Makers
- 8
- Updated
- Nov 11
Prasugrel price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 5 mg tablet | $0.2574 | $7.72 / 30 tablets |
| 10 mg tablet | $0.2557 | $7.67 / 30 tablets |
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Prasugrel
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use PRASUGREL TABLETS safely and effectively. See full prescribing information for PRASUGREL TABLETS. PRASUGREL tablets, for oral use Initial U.S. Approval: 2009
WARNING: BLEEDING RISK
Prasugrel tablets can cause significant, sometimes fatal, bleeding[see Warnings and Precautions (
5.1,
5.2) and Adverse Reactions (
6.1)].
Do not use prasugrel tablets in patients with active pathological bleeding or a history of transient ischemic attack or stroke[see Contraindications (
4.1,
4.2)].
In patients≥
75 years of age, prasugrel tablets is generally not recommended, because of the increased risk of fatal and intracranial bleeding and uncertain benefit, except in high-risk situations (patients with diabetes or a history of prior myocardial infarction [MI]) where its effect appears to be greater and its use may be considered[see Use in Specific Populations (
8.5)].
Do not start prasugrel tablets in patients likely to undergo urgent coronary artery bypass graft surgery (CABG). When possible, discontinue prasugrel tablets at least 7 days prior to any surgery.[see Warnings and Precautions (
5.2)].
Additional risk factors for bleeding include: body weight <60 kg; propensity to bleed; concomitant use of medications that increase the risk of bleeding (e.g., warfarin, heparin, fibrinolytic therapy, chronic use of non-steroidal anti-inflammatory drugs [NSAIDs])[see Warnings and Precautions (
5.1)].
Suspect bleeding in any patient who is hypotensive and has recently undergone coronary angiography, percutaneous coronary intervention (PCI), CABG, or other surgical procedures in the setting of Prasugrel tablets[see Warnings and Precautions (
5.1)].
If possible, manage bleeding without discontinuing prasugrel tablets. Discontinuing prasugrel tablets, particularly in the first few weeks after acute coronary syndrome, increases the risk of subsequent cardiovascular (CV) events[see Warnings and Precautions (
5.3)]
WARNING: BLEEDING RISK
See full prescribing information for complete boxed warning.
PRASUGREL tablets can cause significant, sometimes fatal, bleeding (
5.1,
5.2,
6.1).
Do not use PRASUGREL tablets in patients with active pathological bleeding or a history of transient ischemic attack or stroke (
4.1,
4.2).
In patients ≥ 75 years of age, prasugrel tablets is generally not recommended, except in high-risk patients (diabetes or prior MI), where its use may be considered (8.5).
Do not start Prasugrel tablets in patients likely to undergo urgent coronary artery bypass graft surgery (CABG). When possible, discontinue Prasugrel tablets at least 7 days prior to any surgery (5.2).
Additional risk factors for bleeding include: body weight <60 kg; propensity to bleed; concomitant use of medications that increase the risk of bleeding (5.1).
Suspect bleeding in any patient who is hypotensive and has recently undergone invasive or surgical procedures (5.1).
If possible, manage bleeding without discontinuing Prasugrel tablets. Stopping Prasugrel tablets increases the risk of subsequent cardiovascular events (5.3)
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Generic makers
- 6 approved generic applications on the market
Prasugrel questions
How much does prasugrel cost without insurance?
Pharmacies pay about $7.67 for 30 tablets of prasugrel 10 mg tablet ($0.2557 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $19.32. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is prasugrel in shortage?
No shortage is reported for prasugrel right now. We check the national shortage list every day.
Has prasugrel been recalled?
5 recalls on record, 4 ongoing. Recalls name specific lots - check yours.
When did the prasugrel label last change?
The official label was last updated on November 9, 2026 (version 10). See what changed.
Talk about prasugrel
No comments yet. Questions, tips, what worked for you - start the conversation.